$3.04
Today
as of Oct 2, 16:48 ET
Last 30 days
Recent Press Releases & News
Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic
Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND
Ernexa Therapeutics Selected for Emerging Track at 2026 Cell & Gene Meeting on the Mesa, Highlighting ERNA-101 and Focused Oncology Strategy
ERNA earnings at a glance
Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±2.1% on average; after the most recent report on May 11, 2026 it moved -4.2%. The share price of $3.04 sits near its 52-week low.
Overview
52-week range
$2.84
$72
0% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-2.1%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-3.40 | — | — | — | — | financials |
| Mon May 11, 2026 | Mar/2026 | $-6.95 | — | — | -4,533% | -4.2% | earnings |
| Fri Nov 7, 2025 | Sep/2025 | $-0.15 | — | — | — | — | earnings |
| Wed Aug 13, 2025 | Jun/2025 | $-0.61 | — | — | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $-0.15 | — | — | — | 0.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-73.70 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-15.34 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.23 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.03 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.85 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-1.06 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $487,000 |
| Cost of revenue | $0 | — | — | — | $0 | — | — | $-60,000 |
| Gross profit | — | — | — | — | — | — | — | $547,000 |
| Operating income | $-4M | $-6M | — | $-2M | $-3M | $-3M | — | $-2M |
| Net income | $-4M | $-6M | — | $-1M | $-3M | $-8M | — | $-27M |
| EPS (diluted) | $-3.40 | $-6.95 | — | $-0.15 | $-15.19 | $-57.76 | — | $-73.70 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $5M | $9M | $2M | $3M | $4M | $2M | — | $4M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $6M | $10M | $3M | $3M | $5M | $2M | $2M | $5M |
| Total assets | $6M | $11M | $6M | $6M | $8M | $5M | $5M | $8M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $3M | $4M | $3M | $3M | $3M | $11M | $4M | $53M |
| Total equity | $3M | $7M | $2M | $4M | $4M | $-6M | $2M | $-45M |
Implied volatility — last 90 days
No IV snapshots yet for ERNA.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
ERNA earnings FAQ
How does ERNA stock usually react to earnings?
Across the last 2 reports the average next-day move was ±2.1%, up 0 times and down 2 times.